Promega launches XpressAmp Direct Amplification reagents
The reagents are designed to allow COVID-19 testing labs to skip the RNA extraction process
Breaking News
Enesi Pharma hits milestone in thermostable solid-dose live vaccines development
Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella
NerPharMa and ICROM partner on highly potent drugs and ADC-payloads
This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies
Evonik delivers first lipids from German facility to BioNTech
The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
Accelerating excipient development for inhalable dosage forms with QbD
Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...
DMC and Conagen partner to manufacture L-alanine
L-alanine is a naturally occurring amino acid used in homecare products, human nutrition, and pharmaceutical ...
CordenPharma expands lipid excipients purification
The company has been continuously investing in expanded lipid supply chain at its facilities in Switzerland, France, ...
Harnessing the power of HPAPIs: key considerations
Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...
Delegate tickets now on sale for Manufacturing Chemist Live
Taking place on 14-15 September, the event will provide a comprehensive overview on key pharmaceutical practices and ...
Recipharm and binx announce long-term supply agreement
Recipharm is a minority investor in binx health
Bispecific antibodies in review: from cell line development to manufacturing
With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...
API sourcing: what to look for in a supplier
Jonathan Knight, Director of Market Intelligence and New Technologies at Cambrex, presents an overview of the API ...
Bispecific antibodies: an exciting new class of emerging therapeutics
Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...
Aker signs pharmaceutical agreement for Lysoveta therapies
Aker BioMarine will continue to seek partnerships within the pharmaceutical space to develop other therapies based on ...
Rousselot extends SiMoGel capabilities with centre-filled soft gummies
The innovative, technical features of this new dosage form invented by Rousselot will be fully detailed in R ...
In Brief
Most Popular in Ingredients
- NerPharMa and ICROM partner on highly potent drugs and ADC-payloads
- Beximco Pharma introduces first generic remdesivir for COVID-19
- Enesi Pharma hits milestone in thermostable solid-dose live vaccines development
- Biocatalysis versus chemocatalysis
- Bispecific antibodies in review: from cell line development to manufacturing
Featured Companies
Reports
